Stockreport

Opdivo (nivolumab) Plus Yervoy (ipilimumab) Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF First I-O/I-O combination regimen to demonstrate response rates in this hard-to-treat patient population PRINCETON, N.J.--(BUSINESS WIRE)-- Br [Read more]